Evolution of radiation-induced dermatitis treatment
Radiation-induced skin damage (RID) is the most prevalent, significant side effect of radiotherapy (RT). Nearly 95% of patients experience moderate to severe skin reactions after receiving radiation therapy. However, criteria for acute radiation dermatitis (ARD) treatment remain unavailable. Topical...
Saved in:
| Published in | Clinical & translational oncology Vol. 26; no. 9; pp. 2142 - 2155 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cham
Springer International Publishing
01.09.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Radiation-induced skin damage (RID) is the most prevalent, significant side effect of radiotherapy (RT). Nearly 95% of patients experience moderate to severe skin reactions after receiving radiation therapy. However, criteria for acute radiation dermatitis (ARD) treatment remain unavailable. Topical agents with anti-inflammatory properties may protect the skin and facilitate tissue regeneration in patients with RID. Many of these topical agents function through nuclear factor kappa B pathway regulation. They either reduce the levels of inflammatory factors or elicit anti-inflammatory properties of their own, thus preventing oxidative stress and inflammatory responses and thus enabling RID prevention and management. Herein, we explore the 25 topical agents investigated for RID prevention and management thus far and evaluate their mechanisms of action. These agents include 11 natural agents, 3 miscellaneous agents, 9 topical nonsteroidal agents, and 2 topical corticosteroids. |
|---|---|
| AbstractList | Radiation-induced skin damage (RID) is the most prevalent, significant side effect of radiotherapy (RT). Nearly 95% of patients experience moderate to severe skin reactions after receiving radiation therapy. However, criteria for acute radiation dermatitis (ARD) treatment remain unavailable. Topical agents with anti-inflammatory properties may protect the skin and facilitate tissue regeneration in patients with RID. Many of these topical agents function through nuclear factor kappa B pathway regulation. They either reduce the levels of inflammatory factors or elicit anti-inflammatory properties of their own, thus preventing oxidative stress and inflammatory responses and thus enabling RID prevention and management. Herein, we explore the 25 topical agents investigated for RID prevention and management thus far and evaluate their mechanisms of action. These agents include 11 natural agents, 3 miscellaneous agents, 9 topical nonsteroidal agents, and 2 topical corticosteroids. Radiation-induced skin damage (RID) is the most prevalent, significant side effect of radiotherapy (RT). Nearly 95% of patients experience moderate to severe skin reactions after receiving radiation therapy. However, criteria for acute radiation dermatitis (ARD) treatment remain unavailable. Topical agents with anti-inflammatory properties may protect the skin and facilitate tissue regeneration in patients with RID. Many of these topical agents function through nuclear factor kappa B pathway regulation. They either reduce the levels of inflammatory factors or elicit anti-inflammatory properties of their own, thus preventing oxidative stress and inflammatory responses and thus enabling RID prevention and management. Herein, we explore the 25 topical agents investigated for RID prevention and management thus far and evaluate their mechanisms of action. These agents include 11 natural agents, 3 miscellaneous agents, 9 topical nonsteroidal agents, and 2 topical corticosteroids.Radiation-induced skin damage (RID) is the most prevalent, significant side effect of radiotherapy (RT). Nearly 95% of patients experience moderate to severe skin reactions after receiving radiation therapy. However, criteria for acute radiation dermatitis (ARD) treatment remain unavailable. Topical agents with anti-inflammatory properties may protect the skin and facilitate tissue regeneration in patients with RID. Many of these topical agents function through nuclear factor kappa B pathway regulation. They either reduce the levels of inflammatory factors or elicit anti-inflammatory properties of their own, thus preventing oxidative stress and inflammatory responses and thus enabling RID prevention and management. Herein, we explore the 25 topical agents investigated for RID prevention and management thus far and evaluate their mechanisms of action. These agents include 11 natural agents, 3 miscellaneous agents, 9 topical nonsteroidal agents, and 2 topical corticosteroids. |
| Author | Jibing, Chen Guangmei, Deng Weishan, He Wenya, Liu Fasheng, Wu |
| Author_xml | – sequence: 1 givenname: Deng surname: Guangmei fullname: Guangmei, Deng organization: Graduate School, Guangxi University of Chinese Medicine – sequence: 2 givenname: He surname: Weishan fullname: Weishan, He organization: Graduate School, Guangxi University of Chinese Medicine – sequence: 3 givenname: Liu surname: Wenya fullname: Wenya, Liu organization: Graduate School, Guangxi University of Chinese Medicine – sequence: 4 givenname: Wu surname: Fasheng fullname: Fasheng, Wu email: 840766676@qq.com organization: Ruikang Hospital, Guangxi University of Chinese Medicine – sequence: 5 givenname: Chen orcidid: 0000-0001-8596-2126 surname: Jibing fullname: Jibing, Chen email: jibingchen398@163.com organization: Ruikang Hospital, Guangxi University of Chinese Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38594379$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kE1PAyEQhompsbX6BzyYHr2swgK7cDRN_UiaeNEzYYE1NLtQgTXx30u7bWI89DCZgTzvJPNcgonzzgBwg-A9grB-iKiEnBSwzIVJBQt0Bmao4rzAkNLJn3kKLmPcwDxVCF2AKWaUE1zzGcCrb98NyXq38O0iSG3l7lFYpwdl9EKb0OefZOMiBSNTb1y6Auet7KK5PvQ5-HhavS9fivXb8-vycV0oTOpUSAZLDlGpcS0byDglhDBKZCV1Q1ELkZSs0RRhTUuueM1qpTRVraaNJLIt8RzcjXu3wX8NJibR26hM10ln_BAFhphSAglmGb09oEPTGy22wfYy_IjjoRlgI6CCjzGYViib9qemIG0nEBQ7p2J0KrJTsXcqUI6W_6LH7SdDeAzFDLtPE8TGD8FlXadSvwE9iBQ |
| CitedBy_id | crossref_primary_10_62347_XLGT5405 crossref_primary_10_1007_s00520_025_09147_9 |
| Cites_doi | 10.3390/pharmaceutics15010081 10.3390/molecules25061324 10.1016/j.phrs.2016.07.004 10.1016/j.fitote.2012.10.003 10.1177/1534735418803766 10.1111/wrr.12486 10.1111/bcp.14238 10.3390/ijms21051744 10.1038/srep42995 10.3390/nu12061675 10.1007/s00520-023-07656-z 10.1016/j.ijrobp.2020.08.040 10.1177/15347354231164600 10.1016/S1470-2045(23)00067-0 10.1186/s13014-014-0297-0 10.4103/ijd.IJD_607_18 10.1002/biof.1716 10.1007/s00228-018-2570-x 10.1002/ptr.7894 10.3831/KPI.2019.22.027 10.3390/molecules26154429 10.4103/0974-8490.204647 10.1007/s00520-023-07820-5 10.1177/1534735420920714 10.3390/md18080377 10.1002/ptr.6905 10.3892/ijmm_00000545 10.2174/1871530320666200705212107 10.1016/j.clnesp.2021.03.030 10.1111/ajd.12762 10.1016/j.jep.2016.10.031 10.1259/bjr.20150665 10.1007/s00520-013-2031-0 10.1080/10408398.2016.1277971 10.1016/j.pedn.2019.02.001 10.18632/aging.103932 10.1097/COC.0000000000000460 10.1111/wrr.12737 10.1001/jama.2019.3504 10.1111/dth.15334 10.1002/ptr.6231 10.1259/bjr.20130490 10.4103/1735-5362.212052 10.1155/2018/8367846 10.1016/j.mrfmmm.2018.07.001 10.1634/theoncologist.2014-0381 10.1111/iwj.13210 10.1016/j.ijrobp.2011.09.021 10.1007/s00520-019-04957-0 10.1155/2022/7993579 10.1111/1440-1681.12848 10.3389/fphar.2022.976698 10.1016/j.ijrobp.2021.05.133 10.1667/RR3255.1 10.1007/s00520-023-07677-8 10.1155/2016/9481413 10.1093/jrr/rru047 10.1007/s00403-015-1559-x 10.3389/fphar.2017.00354 10.2147/BCTT.S109763 10.3390/ijerph17228452 10.1016/j.ejphar.2005.12.034 10.1007/s12325-020-01251-y 10.3390/ph15101284 10.1016/j.ijrobp.2014.06.034 10.1016/j.jaad.2019.02.047 10.3390/ijms23074004 10.1590/0034-7167-2019-0815 10.1016/j.ctim.2019.102205 10.1097/SHK.0000000000000752 10.1016/j.ejon.2022.102164 10.1007/s00520-011-1110-3 10.1007/s12032-017-0886-5 10.1001/jamadermatol.2022.1736 10.1016/j.bbagrm.2015.11.001 10.1159/000501730 10.3390/foods6090077 10.1007/s00520-021-06141-9 10.1016/j.ejon.2018.04.003 10.2147/ccid.s322228 10.3390/ijms23084385 10.3390/md20040243 10.3290/j.ohpd.a33091 10.1080/09553002.2018.1440092 10.1016/j.jpainsymman.2019.03.017 10.1159/000496062 10.3390/ph16040611 10.1016/j.eclinm.2023.101886 10.1177/1534734620923912 10.21873/invivo.12851 10.1016/j.radonc.2016.07.005 10.1016/j.fct.2020.111699 10.1371/journal.pone.0143528 10.1007/s00520-019-05166-5 10.1007/s00520-022-06828-7 10.1016/j.ijnurstu.2018.08.007 10.1002/jbt.22424 10.1016/j.phymed.2017.02.005 10.2147/CMAR.S188655 10.1097/MD.0000000000018230 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO). |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO). |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1007/s12094-024-03460-1 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1699-3055 |
| EndPage | 2155 |
| ExternalDocumentID | 38594379 10_1007_s12094_024_03460_1 |
| Genre | Journal Article Review |
| GroupedDBID | -05 -0E -5E -5G -BR -EM -S~ -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29B 29~ 2B. 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VR 5VS 67Z 6NX 8TC 8UJ 92I 92M 93N 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACZOJ ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD B-. BA0 BDATZ BGNMA BSONS CAG CCEZO CHBEP CIEJG COF CS3 CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD EN4 ESBYG F5P FA0 FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG5 HG6 HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXD IZQ I~X I~Z J-C J0Z JBSCW JUIAU JZLTJ KOV KPH LLZTM M4Y MA- NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P2P P9S PF0 PT4 Q-- Q-4 QOR QOS R89 R9I ROL RPX RSV RT5 S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 T8U TCJ TSG TSK TSV TT1 TUC U1F U1G U2A U5O U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z45 Z7D Z7U Z82 Z87 ZMTXR ZOVNA ~A9 ~N8 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c347t-a8029012d37ab0895444854a6adb51f01aa8bd513d529c9787ccd5cfd5ba4af23 |
| IEDL.DBID | U2A |
| ISSN | 1699-3055 |
| IngestDate | Fri Jul 11 12:22:05 EDT 2025 Thu Apr 03 07:08:48 EDT 2025 Thu Apr 24 22:58:33 EDT 2025 Tue Jul 01 03:55:55 EDT 2025 Fri Feb 21 02:38:29 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | Topical corticosteroids Topical treatment Natural agents Radiation-induced skin reactions Miscellaneous agent Radiotherapy Topical nonsteroidal agents |
| Language | English |
| License | 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c347t-a8029012d37ab0895444854a6adb51f01aa8bd513d529c9787ccd5cfd5ba4af23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-8596-2126 |
| PMID | 38594379 |
| PQID | 3035540438 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | proquest_miscellaneous_3035540438 pubmed_primary_38594379 crossref_citationtrail_10_1007_s12094_024_03460_1 crossref_primary_10_1007_s12094_024_03460_1 springer_journals_10_1007_s12094_024_03460_1 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-09-01 |
| PublicationDateYYYYMMDD | 2024-09-01 |
| PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Italy |
| PublicationTitle | Clinical & translational oncology |
| PublicationTitleAbbrev | Clin Transl Oncol |
| PublicationTitleAlternate | Clin Transl Oncol |
| PublicationYear | 2024 |
| Publisher | Springer International Publishing |
| Publisher_xml | – name: Springer International Publishing |
| References | Ronchetti, Impagnatiello, Guzzetta, Gasparini, Borgatti, Gambari (CR88) 2006 Karbasforooshan, Hosseini, Elyasi, Fani Pakdel, Karimi (CR8) 2019; 33 Anderson, Lalla (CR62) 2020 Pessoa, Florim, Rodrigues, Andrade-Oliveira, Teixeira, Vitzel (CR66) 2016; 24 Majdalawieh, Fayyad, Nasrallah (CR24) 2017; 57 Pinnix, Perkins, Strom, Tereffe, Woodward, Oh (CR75) 2012 Yang, Gong, Jin, Han, Zhuo, Yang (CR43) 2019 Bala, Chugh, Bansal, Garg, Koul (CR55) 2018 Abtahi-Naeini, Saffaei, Sabzghabaee, Amiri, Hosseini, Niknami (CR90) 2022; 35 Ryan, Heckler, Ling, Katz, Williams, Pentland (CR29) 2013; 180 Karbasizade, Ghorbani, Ghasemi Darestani, Mansouri-Tehrani, Kazemi (CR50) 2021; 13 Yang, Lin, Korivi, Wu, Liao, Chang (CR87) 2016; 1859 Rafati, Ghasemi, Saeedi, Habibi, Salehifar, Mosazadeh (CR22) 2019 Hossen, Yang, Kim, Aravinthan, Kim, Cho (CR25) 2017 Cruceriu, Balacescu, Rakosy (CR10) 2018; 17 Franco, Potenza, Moretto, Segantin, Grosso, Lombardo (CR61) 2014 Robijns, Becherini, Caini, Wolf, van den Hurk, Beveridge (CR37) 2023; 31 Abbas, Bensadoun (CR91) 2012; 20 Liao, Feng, Dai, Long, Tang, Pu (CR98) 2019; 98 Han, Xu, Guo, Huang (CR33) 2018; 45 Ferreira, Macedo, Silva, Delerue-Matos, Costa, Rodrigues (CR16) 2022; 23 Cinausero, Aprile, Ermacora, Basile, Vitale, Fanotto (CR67) 2017 Thanthong, Nanthong, Kongwattanakul, Laebua, Trirussapanich, Pitiporn (CR39) 2020 Koukourakis, Pissakas, Ganos, Sivolapenko, Kardamakis (CR11) 2022; 21 Palatty, Azmidah, Rao, Jayachander, Thilakchand, Rai (CR28) 2014; 87 Lee, Fang, Wang, Chou, Huang (CR79) 2022; 30 Vats, Bhardwaj, Chhabra (CR41) 2021; 21 Geara, Eid, Zouain, Thebian, Andraos, Chehab (CR94) 2018; 41 Zhu, Xu, Ge, Cao, Ge, Luo (CR85) 2014; 55 Tao, Zhu, Duan, Wu, Zhang, Yao (CR72) 2020; 34 Mukherjee, Nema, Maity, Sarkar (CR40) 2013 Jacobs, Hutton, Ng, Shorr, Clemons (CR69) 2015; 20 Fatima, Hirakawa, Marta, Caini, Beveridge, Bonomo (CR77) 2023; 31 Higgins, Izadi, Kaviani (CR68) 2020; 17 Besednova, Andryukov, Zaporozhets, Kuznetsova, Kryzhanovsky, Ermakova (CR18) 2022; 20 Uysal, Gamsiz, Dincoglan, Demiral, Sager, Dirican (CR102) 2020; 65 Givol, Kornhaber, Visentin, Cleary, Haik, Harats (CR15) 2019; 27 Tam, Zhou, Trombetta, Caini, Ryan Wolf, van den Hurk (CR95) 2023; 31 Samarghandian, Farkhondeh, Samini (CR46) 2017; 9 Sanchez, Gonzalez-Burgos, Iglesias, Gomez-Serranillos (CR53) 2020 Juncan, Moisa, Santini, Morgovan, Rus, Vonica-Tincu (CR80) 2021; 26 Kim, Seong, Kim, Jung (CR84) 2022; 23 Rao, Hegde, Rao, Dinkar, Thilakchand, George (CR44) 2017; 6 Nasiri, Ilaghi Nezhad, Sharififar, Khazaneha, Najafzadeh, Mohamadi (CR23) 2022 Simões, Santos, Silva, Silva (CR92) 2020; 73 Wang, Liao, Zheng, Zhou, Jin, Wu (CR52) 2022 Talebi, Farkhondeh, Samarghandian (CR26) 2021; 35 Park, Kwak, Kang, Jung, Lee, Lee (CR58) 2017 Musial, Kuban-Jankowska, Gorska-Ponikowska (CR86) 2020; 21 Maleki, Mardani, Manouchehri, Ashghali Farahani, Vaismoradi, Glarcher (CR19) 2023 Behroozian, Bonomo, Patel, Kanee, Finkelstein, van den Hurk (CR6) 2023; 24 Erridge, McCabe, Porter, Simpson, Stillie (CR100) 2016; 121 Derosa, Maffioli, Simental-Mendia, Bo, Sahebkar (CR32) 2016 Hendawy, Al-Sanea, Elbargisy, Rahman, Mohamed, Kamal (CR38) 2022 Rosenthal, Israilevich, Moy (CR13) 2019; 81 Kondziołka, Wilczyński (CR74) 2021 Bhaskaran, Shukla, Srivastava, Gupta (CR20) 2010; 26 Akbari, Kariznavi, Jannati, Elyasi, Tayarani-Najaran (CR31) 2020 de Sousa, de Lima Dantas, Medrado, Lima, Martins, Carrera (CR63) 2021 Yang, Kim, Park, Ahn, Jung, Oh (CR17) 2020; 18 Rahimi, Mohamad, Albuquerque, Kim, Chen, Thomas (CR76) 2020; 28 Krausz, Adler, Landriscina, Rosen, Musaev, Nosanchuk (CR93) 2015; 307 Shahane, Kshirsagar, Tambe, Jain, Rout, Ferreira (CR14) 2023; 16 Hawley, Hovan, McGahan, Saunders (CR45) 2014; 22 Cui, Xin, Yin, Zhang, Han (CR35) 2015; 8 Presta, Puliatti, Bonetti, Tolotti, Sari, Valcarenghi (CR78) 2019; 16 Spada, Barnes, Greive (CR96) 2018; 59 Kim, Kim (CR59) 2019; 22 Chitapanarux, Tovanabutra, Chiewchanvit, Sripan, Chumachote, Nobnop (CR36) 2019; 14 Kole, Kole, Moran (CR12) 2017 Ryan Wolf, Gewandter, Bautista, Heckler, Strasser, Dyk (CR30) 2020; 28 Wahedi, Jeong, Chae, Do, Yoon, Kim (CR56) 2017 Menon, Prem, Kumari (CR101) 2021; 109 Kong, Hwang, Lee, Yoon (CR57) 2016 Fuzissaki, Paiva, Oliveira, Lajolo Canto, Paiva Maia (CR1) 2019 Tungkasamit, Chakrabandhu, Samakgarn, Kunawongkrit, Jirawatwarakul, Chumachote (CR49) 2022 Holmes, Plichta, Gamelli, Radek (CR97) 2017; 47 Baharara, Rahsepar, Emami, Elyasi, Mohammadpour, Ghavami (CR7) 2023 Sahebjamee, Mansourian, Hajimirzamohammad, Zadeh, Bekhradi, Kazemian (CR51) 2015; 13 Shariati, Amouheidari, Naji Esfahani, Abed, Haghjooy Javanmard, Laher (CR71) 2020; 86 Yang, Ren, Guo, Hu, Fu (CR3) 2020 Ghasemi, Ghashghai, Akbari, Yazdani-Charati, Salehifar, Hosseinimehr (CR81) 2019; 75 Franco, Rampino, Ostellino, Schena, Pecorari, Garzino Demo (CR60) 2017; 34 Gillessen, Schmidt (CR9) 2020; 37 Zabihi, Hajhashemi, Minaiyan, Talebi (CR73) 2017; 12 Yokota, Zenda, Ota, Yamazaki, Yamaguchi, Ogawa (CR2) 2021; 111 Ahmed, Sulaiman, Baig, Ibrahim, Liaqat, Fatima (CR47) 2018 Chan, Mann, Tripcony, Keller, Cheuk, Blades (CR89) 2014; 90 Najafi, Motevaseli, Shirazi, Geraily, Rezaeyan, Norouzi (CR4) 2018; 94 Sio, Le-Rademacher, Leenstra, Loprinzi, Rine, Curtis (CR70) 2019; 321 Memarzia, Khazdair, Behrouz, Gholamnezhad, Jafarnezhad, Saadat (CR27) 2021; 47 Behroozian, Goldshtein, Ryan Wolf, van den Hurk, Finkelstein, Lam (CR99) 2023 Sah, Naseef, Kuruniyan, Jain, Zakir, Aggarwal (CR21) 2022; 15 Kao, Ma, Wu, Wu, Tu, Hung (CR34) 2022 Konuk Sener, Aydin, Cangur, Guven (CR65) 2019 Zhao, Zhu, Jia, Sun, Chen, Zhao (CR83) 2016; 89 Wei, Meng, Hou, Qu, Wang, Xin (CR5) 2019 Rekik, Ben Khedir, Daoud, Ksouda Moalla, Rebai, Sahnoun (CR48) 2019; 32 Liu, Liu, Wang, Tsai, Yu (CR54) 2015; 10 Charalambous, Raftopoulos, Paikousis, Katodritis, Lambrinou, Vomvas (CR42) 2018 Yarom, Hovan, Bossi, Ariyawardana, Jensen, Gobbo (CR64) 2021; 29 Zhao, Zhu, Zhao, Li, Zhou, Zheng (CR82) 2022; 158 B Uysal (3460_CR102) 2020; 65 M Sahebjamee (3460_CR51) 2015; 13 Y Liao (3460_CR98) 2019; 98 S Han (3460_CR33) 2018; 45 S Rao (3460_CR44) 2017; 6 YS Kao (3460_CR34) 2022 F Tao (3460_CR72) 2020; 34 X Yang (3460_CR3) 2020 A Menon (3460_CR101) 2021; 109 OM Hendawy (3460_CR38) 2022 O Givol (3460_CR15) 2019; 27 G Derosa (3460_CR32) 2016 A Rosenthal (3460_CR13) 2019; 81 H Baharara (3460_CR7) 2023 T Yokota (3460_CR2) 2021; 111 P Franco (3460_CR60) 2017; 34 M Zabihi (3460_CR73) 2017; 12 S Samarghandian (3460_CR46) 2017; 9 TT Sio (3460_CR70) 2019; 321 AE Krausz (3460_CR93) 2015; 307 D Ronchetti (3460_CR88) 2006 A Rahimi (3460_CR76) 2020; 28 MA Fuzissaki (3460_CR1) 2019 D Cruceriu (3460_CR10) 2018; 17 S Bala (3460_CR55) 2018 SR Kim (3460_CR84) 2022; 23 FW Liu (3460_CR54) 2015; 10 W Zhu (3460_CR85) 2014; 55 PL Palatty (3460_CR28) 2014; 87 AS Ferreira (3460_CR16) 2022; 23 M Talebi (3460_CR26) 2021; 35 J Ryan Wolf (3460_CR30) 2020; 28 S Karbasizade (3460_CR50) 2021; 13 A Ghasemi (3460_CR81) 2019; 75 S Ahmed (3460_CR47) 2018 EH Kim (3460_CR59) 2019; 22 P Hawley (3460_CR45) 2014; 22 K Yang (3460_CR17) 2020; 18 MJ Hossen (3460_CR25) 2017 AJ Kole (3460_CR12) 2017 C Yang (3460_CR43) 2019 AM Juncan (3460_CR80) 2021; 26 M Vats (3460_CR41) 2021; 21 H Karbasforooshan (3460_CR8) 2019; 33 T Wang (3460_CR52) 2022 A Memarzia (3460_CR27) 2021; 47 N Bhaskaran (3460_CR20) 2010; 26 CJ Holmes (3460_CR97) 2017; 47 PK Mukherjee (3460_CR40) 2013 S Tam (3460_CR95) 2023; 31 A Sah (3460_CR21) 2022; 15 S Akbari (3460_CR31) 2020 S Thanthong (3460_CR39) 2020 RJ Chan (3460_CR89) 2014; 90 MA de Sousa (3460_CR63) 2021 K Shahane (3460_CR14) 2023; 16 JL Ryan (3460_CR29) 2013; 180 J Robijns (3460_CR37) 2023; 31 A Gillessen (3460_CR9) 2020; 37 M Cinausero (3460_CR67) 2017 I Chitapanarux (3460_CR36) 2019; 14 J Kondziołka (3460_CR74) 2021 SC Erridge (3460_CR100) 2016; 121 NN Besednova (3460_CR18) 2022; 20 AF Pessoa (3460_CR66) 2016; 24 L Shariati (3460_CR71) 2020; 86 MR Higgins (3460_CR68) 2020; 17 M Kong (3460_CR57) 2016 C Musial (3460_CR86) 2020; 21 HM Wahedi (3460_CR56) 2017 Z Cui (3460_CR35) 2015; 8 DM Rekik (3460_CR48) 2019; 32 JY Park (3460_CR58) 2017 J Wei (3460_CR5) 2019 HL Yang (3460_CR87) 2016; 1859 T Behroozian (3460_CR99) 2023 F Spada (3460_CR96) 2018; 59 B Abtahi-Naeini (3460_CR90) 2022; 35 H Zhao (3460_CR83) 2016; 89 N Yarom (3460_CR64) 2021; 29 M Rafati (3460_CR22) 2019 AF Majdalawieh (3460_CR24) 2017; 57 S Fatima (3460_CR77) 2023; 31 N Nasiri (3460_CR23) 2022 D Konuk Sener (3460_CR65) 2019 C Jacobs (3460_CR69) 2015; 20 H Abbas (3460_CR91) 2012; 20 M Sanchez (3460_CR53) 2020 T Tungkasamit (3460_CR49) 2022 FV Simões (3460_CR92) 2020; 73 FB Geara (3460_CR94) 2018; 41 PM Anderson (3460_CR62) 2020 M Najafi (3460_CR4) 2018; 94 M Maleki (3460_CR19) 2023 P Franco (3460_CR61) 2014 CJ Lee (3460_CR79) 2022; 30 C Pinnix (3460_CR75) 2012 G Koukourakis (3460_CR11) 2022; 21 G Presta (3460_CR78) 2019; 16 M Charalambous (3460_CR42) 2018 T Behroozian (3460_CR6) 2023; 24 H Zhao (3460_CR82) 2022; 158 |
| References_xml | – year: 2022 ident: CR38 article-title: Phenylboronic acid-grafted chitosan nanocapsules for effective delivery and controllable release of natural antioxidants: Olive oil and hydroxytyrosol publication-title: Pharmaceutics doi: 10.3390/pharmaceutics15010081 – volume: 8 start-page: 11000 issue: 7 year: 2015 end-page: 11006 ident: CR35 article-title: Topical use of olive oil preparation to prevent radiodermatitis: results of a prospective study in nasopharyngeal carcinoma patients publication-title: Int J Clin Exp Med – year: 2020 ident: CR53 article-title: Pharmacological update properties of aloe vera and its major active constituents publication-title: Molecules doi: 10.3390/molecules25061324 – year: 2016 ident: CR32 article-title: Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials publication-title: Pharmacol Res doi: 10.1016/j.phrs.2016.07.004 – year: 2013 ident: CR40 article-title: Phytochemical and therapeutic potential of cucumber publication-title: Fitoterapia doi: 10.1016/j.fitote.2012.10.003 – volume: 17 start-page: 1068 issue: 4 year: 2018 end-page: 1078 ident: CR10 article-title: Calendula officinalis: potential roles in cancer treatment and palliative care publication-title: Integr Cancer Ther doi: 10.1177/1534735418803766 – volume: 24 start-page: 981 issue: 6 year: 2016 end-page: 993 ident: CR66 article-title: Oral administration of antioxidants improves skin wound healing in diabetic mice publication-title: Wound Repair Regen doi: 10.1111/wrr.12486 – volume: 86 start-page: 1875 issue: 9 year: 2020 end-page: 1881 ident: CR71 article-title: Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.14238 – volume: 21 start-page: 1744 issue: 5 year: 2020 ident: CR86 article-title: Beneficial properties of green tea catechins publication-title: Int J Mol Sci doi: 10.3390/ijms21051744 – year: 2017 ident: CR25 article-title: Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities publication-title: Sci Rep doi: 10.1038/srep42995 – year: 2020 ident: CR62 article-title: Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy publication-title: Nutrients doi: 10.3390/nu12061675 – volume: 31 start-page: 195 issue: 3 year: 2023 ident: CR37 article-title: Natural and miscellaneous agents for the prevention of acute radiation dermatitis: a systematic review and meta-analysis publication-title: Support Care Cancer doi: 10.1007/s00520-023-07656-z – volume: 109 start-page: 151 issue: 1 year: 2021 end-page: 160 ident: CR101 article-title: Topical betamethasone valerate as a prophylactic agent to prevent acute radiation dermatitis in head and neck malignancies: A randomized, open-Label, phase 3 trial publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2020.08.040 – year: 2023 ident: CR19 article-title: Effect of chamomile on the complications of cancer: a systematic review publication-title: Integr Cancer Ther doi: 10.1177/15347354231164600 – volume: 24 start-page: e172 issue: 4 year: 2023 end-page: e185 ident: CR6 article-title: Multinational association of supportive care in cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international delphi consensus-based recommendations publication-title: Lancet Oncol doi: 10.1016/S1470-2045(23)00067-0 – year: 2014 ident: CR61 article-title: Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study publication-title: Radiat Oncol doi: 10.1186/s13014-014-0297-0 – volume: 65 start-page: 279 issue: 4 year: 2020 end-page: 283 ident: CR102 article-title: Comparative evaluation of topical corticosteroid and moisturizer in the prevention of radiodermatitis in breast cancer radiotherapy publication-title: Indian J Dermatol doi: 10.4103/ijd.IJD_607_18 – volume: 47 start-page: 311 issue: 3 year: 2021 end-page: 350 ident: CR27 article-title: Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review publication-title: BioFactors doi: 10.1002/biof.1716 – volume: 13 start-page: 110 issue: 4 year: 2021 end-page: 116 ident: CR50 article-title: Comparison of therapeutic effects of statins and aloe vera mouthwash on chemotherapy induced oral mucositis publication-title: Int J Physiol Pathophysiol Pharmacol – volume: 75 start-page: 171 issue: 2 year: 2019 end-page: 178 ident: CR81 article-title: Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-018-2570-x – year: 2023 ident: CR7 article-title: The efficacy of medicinal plant preparations in the alleviation of radiodermatitis in patients with breast cancer: a systematic review of clinical trials publication-title: Phytother Res doi: 10.1002/ptr.7894 – volume: 22 start-page: 200 issue: 3 year: 2019 end-page: 203 ident: CR59 article-title: Post treatment application of Jaungo after a combined therapy of carbon dioxide laser and trichloroacetic acid in a case of vulvar syringoma publication-title: J Pharmacopuncture doi: 10.3831/KPI.2019.22.027 – volume: 26 start-page: 4429 issue: 15 year: 2021 ident: CR80 article-title: Advantages of hyaluronic acid and its combination with other bioactive ingredients in cosmeceuticals publication-title: Molecules doi: 10.3390/molecules26154429 – volume: 9 start-page: 121 issue: 2 year: 2017 end-page: 127 ident: CR46 article-title: Honey and health: a review of recent clinical research publication-title: Pharmacognosy Res doi: 10.4103/0974-8490.204647 – volume: 31 start-page: 382 issue: 7 year: 2023 ident: CR95 article-title: Topical corticosteroids for the prevention of severe radiation dermatitis: a systematic review and meta-analysis publication-title: Support Care Cancer doi: 10.1007/s00520-023-07820-5 – year: 2020 ident: CR39 article-title: Prophylaxis of radiation-induced dermatitis in patients with breast cancer using herbal creams: a prospective randomized controlled trial publication-title: Integr Cancer Ther doi: 10.1177/1534735420920714 – volume: 18 start-page: 377 issue: 8 year: 2020 ident: CR17 article-title: Topical application of phlorotannins from brown seaweed mitigates radiation dermatitis in a mouse model publication-title: Mar Drugs doi: 10.3390/md18080377 – volume: 35 start-page: 1739 issue: 4 year: 2021 end-page: 1753 ident: CR26 article-title: Biological and therapeutic activities of thymoquinone: Focus on the Nrf2 signaling pathway publication-title: Phytother Res doi: 10.1002/ptr.6905 – volume: 26 start-page: 935 issue: 6 year: 2010 end-page: 940 ident: CR20 article-title: Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity publication-title: Int J Mol Med doi: 10.3892/ijmm_00000545 – volume: 21 start-page: 726 issue: 4 year: 2021 end-page: 733 ident: CR41 article-title: Green synthesis of copper oxide nanoparticles using Cucumis sativus (cucumber) extracts and their bio-physical and biochemical characterization for cosmetic and dermatologic applications publication-title: Endocr Metab Immune Disord Drug Targets doi: 10.2174/1871530320666200705212107 – year: 2021 ident: CR63 article-title: Nutritional supplements in the management of oral mucositis in patients with head and neck cancer: narrative literary review publication-title: Clin Nutr ESPEN doi: 10.1016/j.clnesp.2021.03.030 – volume: 59 start-page: e168 issue: 3 year: 2018 end-page: e174 ident: CR96 article-title: Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids publication-title: Australas J Dermatol doi: 10.1111/ajd.12762 – year: 2017 ident: CR58 article-title: Wound healing effects of deoxyshikonin isolated from Jawoongo: In vitro and in vivo studies publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2016.10.031 – volume: 89 start-page: 20150665 issue: 1058 year: 2016 ident: CR83 article-title: Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy publication-title: Br J Radiol doi: 10.1259/bjr.20150665 – volume: 22 start-page: 751 issue: 3 year: 2014 end-page: 761 ident: CR45 article-title: A randomized placebo-controlled trial of manuka honey for radiation-induced oral mucositis publication-title: Support Care Cancer doi: 10.1007/s00520-013-2031-0 – volume: 57 start-page: 3911 issue: 18 year: 2017 end-page: 3928 ident: CR24 article-title: Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2016.1277971 – year: 2019 ident: CR65 article-title: The effect of oral care with chlorhexidine, vitamin E and honey on mucositis in pediatric intensive care patients: A randomized controlled trial publication-title: J Pediatr Nurs doi: 10.1016/j.pedn.2019.02.001 – year: 2020 ident: CR3 article-title: Radiation-induced skin injury: pathogenesis, treatment, and management publication-title: Aging (Albany NY) doi: 10.18632/aging.103932 – volume: 41 start-page: 1257 issue: 12 year: 2018 end-page: 1262 ident: CR94 article-title: Randomized, prospective, open-label phase III trial comparing mebo ointment with biafine cream for the management of acute dermatitis during radiotherapy for breast cancer publication-title: Am J Clin Oncol doi: 10.1097/COC.0000000000000460 – volume: 27 start-page: 548 issue: 5 year: 2019 end-page: 561 ident: CR15 article-title: A systematic review of calendula officinalis extract for wound healing publication-title: Wound Repair Regen doi: 10.1111/wrr.12737 – volume: 321 start-page: 1481 issue: 15 year: 2019 end-page: 1490 ident: CR70 article-title: Effect of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash vs placebo on radiotherapy-related oral mucositis pain: The alliance a221304 randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2019.3504 – volume: 35 issue: 4 year: 2022 ident: CR90 article-title: Topical sucralfate for treatment of mucocutaneous conditions: A systematic review on clinical evidences publication-title: Dermatol Ther doi: 10.1111/dth.15334 – volume: 33 start-page: 379 issue: 2 year: 2019 end-page: 386 ident: CR8 article-title: Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: a randomized, double-blind, placebo-controlled clinical trial publication-title: Phytother Res doi: 10.1002/ptr.6231 – volume: 87 start-page: 20130490 issue: 1038 year: 2014 ident: CR28 article-title: Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study publication-title: Br J Radiol doi: 10.1259/bjr.20130490 – volume: 12 start-page: 337 issue: 4 year: 2017 end-page: 345 ident: CR73 article-title: Evaluation of the central and peripheral effects of doxepin on carrageenan-induced inflammatory paw edema in rat publication-title: Res Pharm Sci doi: 10.4103/1735-5362.212052 – year: 2018 ident: CR47 article-title: Honey as a potential natural antioxidant medicine: An insight into its molecular mechanisms of action publication-title: Oxid Med Cell Longev doi: 10.1155/2018/8367846 – year: 2018 ident: CR55 article-title: Radiomodulatory effects of Aloe vera on hepatic and renal tissues of X-ray irradiated mice publication-title: Mutat Res doi: 10.1016/j.mrfmmm.2018.07.001 – volume: 20 start-page: 210 issue: 2 year: 2015 end-page: 223 ident: CR69 article-title: Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review publication-title: Oncologist doi: 10.1634/theoncologist.2014-0381 – volume: 16 start-page: 1433 issue: 6 year: 2019 end-page: 1439 ident: CR78 article-title: Effectiveness of hyaluronic acid gel (Jalosome soothing gel) for the treatment of radiodermatitis in a patient receiving head and neck radiotherapy associated with cetuximab: a case report and review publication-title: Int Wound J doi: 10.1111/iwj.13210 – year: 2012 ident: CR75 article-title: Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2011.09.021 – volume: 28 start-page: 1481 issue: 3 year: 2020 end-page: 1489 ident: CR76 article-title: Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial publication-title: Support Care Cancer doi: 10.1007/s00520-019-04957-0 – year: 2022 ident: CR23 article-title: The therapeutic effects of nigella sativa on skin disease: A systematic review and meta-analysis of randomized controlled trials publication-title: Evid Based Complement Alternat Med doi: 10.1155/2022/7993579 – volume: 45 start-page: 84 issue: 1 year: 2018 end-page: 93 ident: CR33 article-title: Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/1440-1681.12848 – year: 2022 ident: CR52 article-title: Aloe vera for prevention of radiation-induced dermatitis: A systematic review and cumulative analysis of randomized controlled trials publication-title: Front Pharmacol doi: 10.3389/fphar.2022.976698 – volume: 111 start-page: 794 issue: 3 year: 2021 end-page: 803 ident: CR2 article-title: Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in patients with head and neck cancer receiving chemoradiation publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2021.05.133 – volume: 180 start-page: 34 issue: 1 year: 2013 end-page: 43 ident: CR29 article-title: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients publication-title: Radiat Res doi: 10.1667/RR3255.1 – volume: 31 start-page: 217 issue: 4 year: 2023 ident: CR77 article-title: Topical non-steroidal agents for the prevention of radiation dermatitis: a systematic review and meta-analysis publication-title: Support Care Cancer doi: 10.1007/s00520-023-07677-8 – year: 2016 ident: CR57 article-title: The efficacy and safety of Jaungo, a traditional medicinal ointment, in preventing radiation dermatitis in patients with breast cancer: a prospective, single-Blinded, randomized pilot study publication-title: Evid Based Complement Alternat Med doi: 10.1155/2016/9481413 – volume: 55 start-page: 1056 issue: 6 year: 2014 end-page: 1065 ident: CR85 article-title: Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression publication-title: J Radiat Res doi: 10.1093/jrr/rru047 – volume: 307 start-page: 583 issue: 7 year: 2015 end-page: 594 ident: CR93 article-title: Biafine topical emulsion accelerates excisional and burn wound healing in mice publication-title: Arch Dermatol Res doi: 10.1007/s00403-015-1559-x – year: 2017 ident: CR67 article-title: New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury publication-title: Front Pharmacol doi: 10.3389/fphar.2017.00354 – year: 2017 ident: CR12 article-title: Acute radiation dermatitis in breast cancer patients: challenges and solutions publication-title: Breast Cancer (Dove Med Press) doi: 10.2147/BCTT.S109763 – volume: 17 start-page: 8452 issue: 22 year: 2020 ident: CR68 article-title: Antioxidants and exercise performance: With a focus on vitamin E and C supplementation publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph17228452 – year: 2006 ident: CR88 article-title: Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.12.034 – volume: 37 start-page: 1279 issue: 4 year: 2020 end-page: 1301 ident: CR9 article-title: Silymarin as supportive treatment in liver diseases: a narrative review publication-title: Adv Ther doi: 10.1007/s12325-020-01251-y – volume: 15 start-page: 1284 issue: 10 year: 2022 ident: CR21 article-title: A comprehensive study of therapeutic applications of chamomile publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph15101284 – volume: 90 start-page: 756 issue: 4 year: 2014 end-page: 764 ident: CR89 article-title: Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2014.06.034 – volume: 81 start-page: 558 issue: 2 year: 2019 end-page: 567 ident: CR13 article-title: Management of acute radiation dermatitis: A review of the literature and proposal for treatment algorithm publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2019.02.047 – volume: 23 start-page: 4004 issue: 7 year: 2022 ident: CR84 article-title: Epigallocatechin gallate protects against hypoxia-induced inflammation in microglia via NF-kappaB suppression and Nrf-2/HO-1 activation publication-title: Int J Mol Sci doi: 10.3390/ijms23074004 – volume: 73 issue: suppl 5 year: 2020 ident: CR92 article-title: Effectiveness of skin protectors and calendula officinalis for prevention and treatment of radiodermatitis: an integrative review publication-title: Rev Bras Enferm doi: 10.1590/0034-7167-2019-0815 – year: 2019 ident: CR22 article-title: Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: a randomized, double-blind, placebo-controlled, clinical trial publication-title: Complement Ther Med doi: 10.1016/j.ctim.2019.102205 – volume: 47 start-page: 175 issue: 2 year: 2017 end-page: 183 ident: CR97 article-title: Burn injury alters epidermal cholinergic mediators and increases HMGB1 and Caspase 3 in autologous donor skin and burn margin publication-title: Shock doi: 10.1097/SHK.0000000000000752 – year: 2022 ident: CR49 article-title: Reduction in severity of radiation-induced dermatitis in head and neck cancer patients treated with topical aloe vera gel: a randomized multicenter double-blind placebo-controlled trial publication-title: Eur J Oncol Nurs doi: 10.1016/j.ejon.2022.102164 – volume: 20 start-page: 185 issue: 1 year: 2012 end-page: 190 ident: CR91 article-title: Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck publication-title: Support Care Cancer doi: 10.1007/s00520-011-1110-3 – volume: 34 start-page: 30 issue: 2 year: 2017 ident: CR60 article-title: Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients publication-title: Med Oncol doi: 10.1007/s12032-017-0886-5 – volume: 158 start-page: 779 issue: 7 year: 2022 end-page: 786 ident: CR82 article-title: Efficacy of Epigallocatechin-3-Gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy: a double-blind, placebo-controlled, phase 2 randomized clinical trial publication-title: JAMA Dermatol doi: 10.1001/jamadermatol.2022.1736 – volume: 1859 start-page: 246 issue: 2 year: 2016 end-page: 261 ident: CR87 article-title: Coenzyme Q0 regulates NFkappaB/AP-1 activation and enhances Nrf2 stabilization in attenuation of LPS-induced inflammation and redox imbalance: Evidence from in vitro and in vivo studies publication-title: Biochim Biophys Acta doi: 10.1016/j.bbagrm.2015.11.001 – volume: 32 start-page: 295 issue: 6 year: 2019 end-page: 306 ident: CR48 article-title: Wound healing effect of lawsonia inermis publication-title: Skin Pharmacol Physiol doi: 10.1159/000501730 – volume: 6 start-page: 77 issue: 9 year: 2017 ident: CR44 article-title: Honey mitigates radiation-induced oral mucositis in head and neck cancer patients without affecting the tumor response publication-title: Foods doi: 10.3390/foods6090077 – volume: 29 start-page: 4175 issue: 7 year: 2021 end-page: 4176 ident: CR64 article-title: Correction to: Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines–part 1: vitamins, minerals and nutritional supplements publication-title: Support Care Cancer doi: 10.1007/s00520-021-06141-9 – year: 2018 ident: CR42 article-title: The effect of the use of thyme honey in minimizing radiation - induced oral mucositis in head and neck cancer patients: A randomized controlled trial publication-title: Eur J Oncol Nurs doi: 10.1016/j.ejon.2018.04.003 – year: 2021 ident: CR74 article-title: Overview of the activei ingredients in cosmetic products for the care of skin that has been exposed to ionizing radiation - Analysis of their effectiveness in breast cancer radiotherapy publication-title: Clin Cosmet Investig Dermatol doi: 10.2147/ccid.s322228 – volume: 23 start-page: 4385 issue: 8 year: 2022 ident: CR16 article-title: Natural products for the prevention and treatment of oral mucositis-a review publication-title: Int J Mol Sci doi: 10.3390/ijms23084385 – volume: 20 start-page: 243 issue: 4 year: 2022 ident: CR18 article-title: Molecular targets of brown algae phlorotannins for the therapy of inflammatory processes of various origins publication-title: Mar Drugs doi: 10.3390/md20040243 – volume: 13 start-page: 309 issue: 4 year: 2015 end-page: 315 ident: CR51 article-title: Comparative efficacy of Aloe vera and benzydamine mouthwashes on radiation-induced oral mucositis: a triple-blind, randomised, controlled clinical trial publication-title: Oral Health Prev Dent doi: 10.3290/j.ohpd.a33091 – volume: 94 start-page: 335 issue: 4 year: 2018 end-page: 356 ident: CR4 article-title: Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications publication-title: Int J Radiat Biol doi: 10.1080/09553002.2018.1440092 – year: 2019 ident: CR1 article-title: The impact of radiodermatitis on breast cancer patients' quality of life during radiotherapy: a prospective cohort study publication-title: J Pain Symptom Manage doi: 10.1016/j.jpainsymman.2019.03.017 – volume: 14 start-page: 394 issue: 6 year: 2019 end-page: 400 ident: CR36 article-title: Emulsion of olive oil and calcium hydroxide for the prevention of radiation dermatitis in hypofractionation post-mastectomy padiotherapy: a randomized controlled trial publication-title: Breast Care (Basel) doi: 10.1159/000496062 – volume: 16 start-page: 611 issue: 4 year: 2023 ident: CR14 article-title: An updated review on the multifaceted therapeutic potential ofcalendula officinalis L publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph16040611 – year: 2023 ident: CR99 article-title: MASCC clinical practice guidelines for the prevention and management of acute radiation dermatitis: part 1 systematic review publication-title: Clin Med doi: 10.1016/j.eclinm.2023.101886 – volume: 21 start-page: 75 issue: 1 year: 2022 end-page: 86 ident: CR11 article-title: Effectiveness and tolerability of natural herbal formulations in the prevention of radiation-Induced skin toxicity in patients undergoing radiotherapy publication-title: Int J Low Extrem Wounds doi: 10.1177/1534734620923912 – year: 2022 ident: CR34 article-title: Topical prevention of radiation dermatitis in head and neck cancer patients: a network meta-analysis publication-title: In Vivo doi: 10.21873/invivo.12851 – volume: 121 start-page: 143 issue: 1 year: 2016 end-page: 147 ident: CR100 article-title: Prospective audit showing improved patient-assessed skin toxicity with use of betamethasone cream for those at high risk of radiation dermatitis publication-title: Radiother Oncol doi: 10.1016/j.radonc.2016.07.005 – year: 2020 ident: CR31 article-title: Curcumin as a preventive or therapeutic measure for chemotherapy and radiotherapy induced adverse reaction: a comprehensive review publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2020.111699 – volume: 10 issue: 12 year: 2015 ident: CR54 article-title: Aloin protects skin fibroblasts from heat stress-induced oxidative stress damage by regulating the oxidative defense system publication-title: PLoS ONE doi: 10.1371/journal.pone.0143528 – volume: 28 start-page: 3303 issue: 7 year: 2020 end-page: 3311 ident: CR30 article-title: Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial publication-title: Support Care Cancer doi: 10.1007/s00520-019-05166-5 – volume: 30 start-page: 3965 issue: 5 year: 2022 end-page: 3975 ident: CR79 article-title: Effect of hyaluronic acid on radiodermatitis in patients with breast cancer: a meta-analysis of randomized controlled trials publication-title: Support Care Cancer doi: 10.1007/s00520-022-06828-7 – year: 2019 ident: CR43 article-title: Topical application of honey in the management of chemo/radiotherapy-induced oral mucositis: A systematic review and network meta-analysis publication-title: Int J Nurs Stud doi: 10.1016/j.ijnurstu.2018.08.007 – volume: 34 issue: 2 year: 2020 ident: CR72 article-title: Anti-inflammatory effects of doxepin hydrochloride against LPS-induced C6-glioma cell inflammatory reaction by PI3K-mediated Akt signaling publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22424 – year: 2017 ident: CR56 article-title: Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad signaling pathways in vitro and in vivo publication-title: Phytomedicine doi: 10.1016/j.phymed.2017.02.005 – year: 2019 ident: CR5 article-title: Radiation-induced skin reactions: mechanism and treatment publication-title: Cancer Manag Res doi: 10.2147/CMAR.S188655 – volume: 98 issue: 52 year: 2019 ident: CR98 article-title: Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000018230 – year: 2019 ident: 3460_CR43 publication-title: Int J Nurs Stud doi: 10.1016/j.ijnurstu.2018.08.007 – volume: 17 start-page: 1068 issue: 4 year: 2018 ident: 3460_CR10 publication-title: Integr Cancer Ther doi: 10.1177/1534735418803766 – volume: 35 issue: 4 year: 2022 ident: 3460_CR90 publication-title: Dermatol Ther doi: 10.1111/dth.15334 – volume: 47 start-page: 311 issue: 3 year: 2021 ident: 3460_CR27 publication-title: BioFactors doi: 10.1002/biof.1716 – volume: 37 start-page: 1279 issue: 4 year: 2020 ident: 3460_CR9 publication-title: Adv Ther doi: 10.1007/s12325-020-01251-y – volume: 59 start-page: e168 issue: 3 year: 2018 ident: 3460_CR96 publication-title: Australas J Dermatol doi: 10.1111/ajd.12762 – volume: 73 issue: suppl 5 year: 2020 ident: 3460_CR92 publication-title: Rev Bras Enferm doi: 10.1590/0034-7167-2019-0815 – volume: 321 start-page: 1481 issue: 15 year: 2019 ident: 3460_CR70 publication-title: JAMA doi: 10.1001/jama.2019.3504 – volume: 31 start-page: 382 issue: 7 year: 2023 ident: 3460_CR95 publication-title: Support Care Cancer doi: 10.1007/s00520-023-07820-5 – volume: 24 start-page: e172 issue: 4 year: 2023 ident: 3460_CR6 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(23)00067-0 – volume: 57 start-page: 3911 issue: 18 year: 2017 ident: 3460_CR24 publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2016.1277971 – year: 2021 ident: 3460_CR63 publication-title: Clin Nutr ESPEN doi: 10.1016/j.clnesp.2021.03.030 – year: 2017 ident: 3460_CR58 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2016.10.031 – volume: 17 start-page: 8452 issue: 22 year: 2020 ident: 3460_CR68 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph17228452 – volume: 81 start-page: 558 issue: 2 year: 2019 ident: 3460_CR13 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2019.02.047 – year: 2018 ident: 3460_CR55 publication-title: Mutat Res doi: 10.1016/j.mrfmmm.2018.07.001 – year: 2017 ident: 3460_CR12 publication-title: Breast Cancer (Dove Med Press) doi: 10.2147/BCTT.S109763 – volume: 31 start-page: 217 issue: 4 year: 2023 ident: 3460_CR77 publication-title: Support Care Cancer doi: 10.1007/s00520-023-07677-8 – volume: 90 start-page: 756 issue: 4 year: 2014 ident: 3460_CR89 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2014.06.034 – year: 2017 ident: 3460_CR67 publication-title: Front Pharmacol doi: 10.3389/fphar.2017.00354 – volume: 16 start-page: 611 issue: 4 year: 2023 ident: 3460_CR14 publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph16040611 – volume: 87 start-page: 20130490 issue: 1038 year: 2014 ident: 3460_CR28 publication-title: Br J Radiol doi: 10.1259/bjr.20130490 – volume: 16 start-page: 1433 issue: 6 year: 2019 ident: 3460_CR78 publication-title: Int Wound J doi: 10.1111/iwj.13210 – volume: 22 start-page: 200 issue: 3 year: 2019 ident: 3460_CR59 publication-title: J Pharmacopuncture doi: 10.3831/KPI.2019.22.027 – volume: 24 start-page: 981 issue: 6 year: 2016 ident: 3460_CR66 publication-title: Wound Repair Regen doi: 10.1111/wrr.12486 – year: 2018 ident: 3460_CR42 publication-title: Eur J Oncol Nurs doi: 10.1016/j.ejon.2018.04.003 – year: 2022 ident: 3460_CR23 publication-title: Evid Based Complement Alternat Med doi: 10.1155/2022/7993579 – volume: 158 start-page: 779 issue: 7 year: 2022 ident: 3460_CR82 publication-title: JAMA Dermatol doi: 10.1001/jamadermatol.2022.1736 – volume: 35 start-page: 1739 issue: 4 year: 2021 ident: 3460_CR26 publication-title: Phytother Res doi: 10.1002/ptr.6905 – year: 2018 ident: 3460_CR47 publication-title: Oxid Med Cell Longev doi: 10.1155/2018/8367846 – volume: 29 start-page: 4175 issue: 7 year: 2021 ident: 3460_CR64 publication-title: Support Care Cancer doi: 10.1007/s00520-021-06141-9 – year: 2021 ident: 3460_CR74 publication-title: Clin Cosmet Investig Dermatol doi: 10.2147/ccid.s322228 – volume: 28 start-page: 1481 issue: 3 year: 2020 ident: 3460_CR76 publication-title: Support Care Cancer doi: 10.1007/s00520-019-04957-0 – volume: 18 start-page: 377 issue: 8 year: 2020 ident: 3460_CR17 publication-title: Mar Drugs doi: 10.3390/md18080377 – volume: 20 start-page: 210 issue: 2 year: 2015 ident: 3460_CR69 publication-title: Oncologist doi: 10.1634/theoncologist.2014-0381 – volume: 121 start-page: 143 issue: 1 year: 2016 ident: 3460_CR100 publication-title: Radiother Oncol doi: 10.1016/j.radonc.2016.07.005 – volume: 111 start-page: 794 issue: 3 year: 2021 ident: 3460_CR2 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2021.05.133 – year: 2023 ident: 3460_CR19 publication-title: Integr Cancer Ther doi: 10.1177/15347354231164600 – year: 2019 ident: 3460_CR22 publication-title: Complement Ther Med doi: 10.1016/j.ctim.2019.102205 – volume: 34 start-page: 30 issue: 2 year: 2017 ident: 3460_CR60 publication-title: Med Oncol doi: 10.1007/s12032-017-0886-5 – volume: 15 start-page: 1284 issue: 10 year: 2022 ident: 3460_CR21 publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph15101284 – volume: 89 start-page: 20150665 issue: 1058 year: 2016 ident: 3460_CR83 publication-title: Br J Radiol doi: 10.1259/bjr.20150665 – volume: 21 start-page: 726 issue: 4 year: 2021 ident: 3460_CR41 publication-title: Endocr Metab Immune Disord Drug Targets doi: 10.2174/1871530320666200705212107 – volume: 9 start-page: 121 issue: 2 year: 2017 ident: 3460_CR46 publication-title: Pharmacognosy Res doi: 10.4103/0974-8490.204647 – volume: 13 start-page: 309 issue: 4 year: 2015 ident: 3460_CR51 publication-title: Oral Health Prev Dent doi: 10.3290/j.ohpd.a33091 – year: 2022 ident: 3460_CR38 publication-title: Pharmaceutics doi: 10.3390/pharmaceutics15010081 – volume: 23 start-page: 4004 issue: 7 year: 2022 ident: 3460_CR84 publication-title: Int J Mol Sci doi: 10.3390/ijms23074004 – year: 2012 ident: 3460_CR75 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2011.09.021 – year: 2019 ident: 3460_CR1 publication-title: J Pain Symptom Manage doi: 10.1016/j.jpainsymman.2019.03.017 – year: 2023 ident: 3460_CR7 publication-title: Phytother Res doi: 10.1002/ptr.7894 – year: 2017 ident: 3460_CR25 publication-title: Sci Rep doi: 10.1038/srep42995 – year: 2016 ident: 3460_CR57 publication-title: Evid Based Complement Alternat Med doi: 10.1155/2016/9481413 – year: 2016 ident: 3460_CR32 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2016.07.004 – volume: 30 start-page: 3965 issue: 5 year: 2022 ident: 3460_CR79 publication-title: Support Care Cancer doi: 10.1007/s00520-022-06828-7 – volume: 10 issue: 12 year: 2015 ident: 3460_CR54 publication-title: PLoS ONE doi: 10.1371/journal.pone.0143528 – volume: 32 start-page: 295 issue: 6 year: 2019 ident: 3460_CR48 publication-title: Skin Pharmacol Physiol doi: 10.1159/000501730 – volume: 45 start-page: 84 issue: 1 year: 2018 ident: 3460_CR33 publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/1440-1681.12848 – volume: 94 start-page: 335 issue: 4 year: 2018 ident: 3460_CR4 publication-title: Int J Radiat Biol doi: 10.1080/09553002.2018.1440092 – volume: 14 start-page: 394 issue: 6 year: 2019 ident: 3460_CR36 publication-title: Breast Care (Basel) doi: 10.1159/000496062 – volume: 22 start-page: 751 issue: 3 year: 2014 ident: 3460_CR45 publication-title: Support Care Cancer doi: 10.1007/s00520-013-2031-0 – volume: 33 start-page: 379 issue: 2 year: 2019 ident: 3460_CR8 publication-title: Phytother Res doi: 10.1002/ptr.6231 – volume: 109 start-page: 151 issue: 1 year: 2021 ident: 3460_CR101 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2020.08.040 – volume: 21 start-page: 75 issue: 1 year: 2022 ident: 3460_CR11 publication-title: Int J Low Extrem Wounds doi: 10.1177/1534734620923912 – year: 2022 ident: 3460_CR52 publication-title: Front Pharmacol doi: 10.3389/fphar.2022.976698 – volume: 55 start-page: 1056 issue: 6 year: 2014 ident: 3460_CR85 publication-title: J Radiat Res doi: 10.1093/jrr/rru047 – volume: 13 start-page: 110 issue: 4 year: 2021 ident: 3460_CR50 publication-title: Int J Physiol Pathophysiol Pharmacol – volume: 8 start-page: 11000 issue: 7 year: 2015 ident: 3460_CR35 publication-title: Int J Clin Exp Med – year: 2014 ident: 3460_CR61 publication-title: Radiat Oncol doi: 10.1186/s13014-014-0297-0 – volume: 41 start-page: 1257 issue: 12 year: 2018 ident: 3460_CR94 publication-title: Am J Clin Oncol doi: 10.1097/COC.0000000000000460 – volume: 180 start-page: 34 issue: 1 year: 2013 ident: 3460_CR29 publication-title: Radiat Res doi: 10.1667/RR3255.1 – volume: 28 start-page: 3303 issue: 7 year: 2020 ident: 3460_CR30 publication-title: Support Care Cancer doi: 10.1007/s00520-019-05166-5 – year: 2022 ident: 3460_CR49 publication-title: Eur J Oncol Nurs doi: 10.1016/j.ejon.2022.102164 – volume: 20 start-page: 243 issue: 4 year: 2022 ident: 3460_CR18 publication-title: Mar Drugs doi: 10.3390/md20040243 – year: 2019 ident: 3460_CR65 publication-title: J Pediatr Nurs doi: 10.1016/j.pedn.2019.02.001 – year: 2020 ident: 3460_CR62 publication-title: Nutrients doi: 10.3390/nu12061675 – year: 2017 ident: 3460_CR56 publication-title: Phytomedicine doi: 10.1016/j.phymed.2017.02.005 – year: 2006 ident: 3460_CR88 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.12.034 – year: 2020 ident: 3460_CR31 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2020.111699 – volume: 26 start-page: 4429 issue: 15 year: 2021 ident: 3460_CR80 publication-title: Molecules doi: 10.3390/molecules26154429 – volume: 23 start-page: 4385 issue: 8 year: 2022 ident: 3460_CR16 publication-title: Int J Mol Sci doi: 10.3390/ijms23084385 – volume: 31 start-page: 195 issue: 3 year: 2023 ident: 3460_CR37 publication-title: Support Care Cancer doi: 10.1007/s00520-023-07656-z – volume: 6 start-page: 77 issue: 9 year: 2017 ident: 3460_CR44 publication-title: Foods doi: 10.3390/foods6090077 – year: 2022 ident: 3460_CR34 publication-title: In Vivo doi: 10.21873/invivo.12851 – volume: 27 start-page: 548 issue: 5 year: 2019 ident: 3460_CR15 publication-title: Wound Repair Regen doi: 10.1111/wrr.12737 – year: 2013 ident: 3460_CR40 publication-title: Fitoterapia doi: 10.1016/j.fitote.2012.10.003 – volume: 1859 start-page: 246 issue: 2 year: 2016 ident: 3460_CR87 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbagrm.2015.11.001 – year: 2020 ident: 3460_CR3 publication-title: Aging (Albany NY) doi: 10.18632/aging.103932 – volume: 86 start-page: 1875 issue: 9 year: 2020 ident: 3460_CR71 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.14238 – year: 2023 ident: 3460_CR99 publication-title: Clin Med doi: 10.1016/j.eclinm.2023.101886 – volume: 12 start-page: 337 issue: 4 year: 2017 ident: 3460_CR73 publication-title: Res Pharm Sci doi: 10.4103/1735-5362.212052 – volume: 98 issue: 52 year: 2019 ident: 3460_CR98 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000018230 – volume: 65 start-page: 279 issue: 4 year: 2020 ident: 3460_CR102 publication-title: Indian J Dermatol doi: 10.4103/ijd.IJD_607_18 – volume: 307 start-page: 583 issue: 7 year: 2015 ident: 3460_CR93 publication-title: Arch Dermatol Res doi: 10.1007/s00403-015-1559-x – volume: 47 start-page: 175 issue: 2 year: 2017 ident: 3460_CR97 publication-title: Shock doi: 10.1097/SHK.0000000000000752 – year: 2020 ident: 3460_CR53 publication-title: Molecules doi: 10.3390/molecules25061324 – volume: 34 issue: 2 year: 2020 ident: 3460_CR72 publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.22424 – volume: 20 start-page: 185 issue: 1 year: 2012 ident: 3460_CR91 publication-title: Support Care Cancer doi: 10.1007/s00520-011-1110-3 – year: 2019 ident: 3460_CR5 publication-title: Cancer Manag Res doi: 10.2147/CMAR.S188655 – year: 2020 ident: 3460_CR39 publication-title: Integr Cancer Ther doi: 10.1177/1534735420920714 – volume: 75 start-page: 171 issue: 2 year: 2019 ident: 3460_CR81 publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-018-2570-x – volume: 26 start-page: 935 issue: 6 year: 2010 ident: 3460_CR20 publication-title: Int J Mol Med doi: 10.3892/ijmm_00000545 – volume: 21 start-page: 1744 issue: 5 year: 2020 ident: 3460_CR86 publication-title: Int J Mol Sci doi: 10.3390/ijms21051744 |
| SSID | ssj0055611 |
| Score | 2.4006662 |
| SecondaryResourceType | review_article |
| Snippet | Radiation-induced skin damage (RID) is the most prevalent, significant side effect of radiotherapy (RT). Nearly 95% of patients experience moderate to severe... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2142 |
| SubjectTerms | Medicine Medicine & Public Health Oncology Review Article |
| Title | Evolution of radiation-induced dermatitis treatment |
| URI | https://link.springer.com/article/10.1007/s12094-024-03460-1 https://www.ncbi.nlm.nih.gov/pubmed/38594379 https://www.proquest.com/docview/3035540438 |
| Volume | 26 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEF6kBfEivo2PEsGbBpJ9JJtjK61FaU8W6mnZV0CQVPrw9zubbFqkUvAQQmA3gdnJznx8O98gdG9ZyhXENYAl0kbUcBlxSmhkCg7phCQqrkRcR-N0OKEvUzb1RWGL5rR7Q0lWO_Wm2A3HTsYWw0VoGkeAedrMYXfw4gnuNvuv6_eY-PKYv-f9DkFbeeUWJ1qFmsEROvQ5YtitF_UY7dnyBO2PPAt-ikj_2ztMOCvCuVMXcA8RwGtYKBMaW-ehH4twfY78DE0G_benYeSbH0Sa0GwZSR47ihMbkkkV85xRAFKMylQaxZIiTqTkyrCEGIZzDVgw09owXRimJJUFJueoVc5Ke4lCThTPeFIAcqA0x1YZrW3m6F-TYZPbACWNPYT2yuCuQcWn2GgaOxsKsKGobCiSAD2s53zVuhg7R981Zhbgvo6TkKWdrRYCIigkNI6ODNBFbf_1-whnuZNLDNBjsyDC_2GLHR-7-t_wa3SAK-dw58ZuUGs5X9lbSDSWqoPa3UGvN3b35_fXfqfysx8x-8sP |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB6kgnoR38ZnBG8aSPaRbI5FWqq2PbXQ27KvgCCtNK2_391k0yKVgoccArsJzMzufMM3-y3Ao6Epkzav2bJEmIhoJiJGMIl0wSycEFjGlYjrYJj2xuRtQif-UFjZdLs3lGS1U68Pu6HYydgi-2CSxpGteXYtGGCukWuM2s3-6-57TPzxmL_n_U5BG7hygxOtUk33CA49RgzbtVOPYcdMT2Bv4FnwU8Cdbx8w4awI505dwL1Etry2jtKhNjUO_SjDVR_5GYy7ndFLL_KXH0QKk2wRCRY7ihNpnAkZs5wSW0hRIlKhJU2KOBGCSU0TrCnKla0FM6U0VYWmUhBRIHwOrelsai4hZFiyjCWFrRwIyZGRWimTOfpXZ0jnJoCksQdXXhncXVDxydeaxs6G3NqQVzbkSQBPqzlftS7G1tEPjZm5DV_HSYipmS1LbjOoBTSOjgzgorb_6nuY0dzJJQbw3DiE-xVWbvnZ1f-G38N-bzTo8_7r8P0aDlAVKK6H7AZai_nS3FrQsZB3VYz9AC8_yvI |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEF6kQvEivo3PCN50afbVbI5FW-qjxYOF3pZ9BQRJS5v6-93No1UqBQ85BHYTmJndmeGb-QaAW8vaXDm_5tISaSE1XEJOCYUm5S6ckERFBYnrYNjuj-jzmI1_dPEX1e41JFn2NHiWpixvTU3aWjW-4chT2mL3ENqOoMt_tt11jLxdj3Cnvov97EdUtcr8ve-3O1qLMdfw0cLt9PbAbhUvhp1Swftgy2YHoDmoEPFDQLpflfGEkzSceaYB_wJdqu2UZkJjy5j0Yx4ua8qPwKjXfX_ow2oQAtSExjmUPPJwJzYkliriCaMuqWJUtqVRDKURkpIrwxAxDCfa5YWx1obp1DAlqUwxOQaNbJLZUxByonjMUeqyCEoTbJXR2sYeCjYxNokNAKrlIXTFEu6HVXyKFb-xl6FwMhSFDAUKwN1yz7TkyNi4-qYWs3Cm7PEJmdnJYi6cN3XBjYcmA3BSyn_5PcJZ4qkTA3BfK0RUp22-4Wdn_1t-DZpvjz3x-jR8OQc7uLATX052ARr5bGEvXfyRq6vCxL4BOE7PLg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evolution+of+radiation-induced+dermatitis+treatment&rft.jtitle=Clinical+%26+translational+oncology&rft.au=Guangmei%2C+Deng&rft.au=Weishan%2C+He&rft.au=Wenya%2C+Liu&rft.au=Fasheng%2C+Wu&rft.date=2024-09-01&rft.pub=Springer+International+Publishing&rft.eissn=1699-3055&rft.volume=26&rft.issue=9&rft.spage=2142&rft.epage=2155&rft_id=info:doi/10.1007%2Fs12094-024-03460-1&rft.externalDocID=10_1007_s12094_024_03460_1 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1699-3055&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1699-3055&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1699-3055&client=summon |